Publications published since 2010 from OUS - Section for Preventive Cardiology
217 publications found
Publications 2024
-
Dissecting unique and common variance across body and brain health indicators using age prediction
Hum Brain Mapp, 45 (6), e26685
DOI 10.1002/hbm.26685, PubMed 38647042 -
Does deep TMS really works for smoking cessation? A prospective, double blind, randomized, sham controlled study
Prog Neuropsychopharmacol Biol Psychiatry, 132, 110997
DOI 10.1016/j.pnpbp.2024.110997, PubMed 38531486 -
Effects on physical activity, physical fitness and well-being in a 36-months randomized controlled study, comparing a multimodal hospital-based intervention programme for primary cardiovascular prevention with usual care
BMC Cardiovasc Disord, 24 (1), 225
DOI 10.1186/s12872-024-03892-1, PubMed 38664620 -
Metabolic Changes Following Smoking Cessation in Patients with Type 2 Diabetes Mellitus
Biomedicines, 12 (8)
DOI 10.3390/biomedicines12081882, PubMed 39200346 -
Self-reported smoking status and exhaled carbon monoxide in secondary preventive follow-up after coronary heart events: Do our patients tell the truth?
Tob Prev Cessat, 10
DOI 10.18332/tpc/191843, PubMed 39323439 -
[Not Available]
Tidsskr Nor Laegeforen, 144
DOI 10.4045/tidsskr.24.0133, PubMed 38738570 -
A multi-component intervention increased access to smoking cessation treatment after hospitalization for atherosclerotic cardiovascular disease: a randomized trial
Eur Heart J Open, 4 (2), oeae028
DOI 10.1093/ehjopen/oeae028, PubMed 38666249 -
Pharmacological treatment of obesity in adults in Norway 2004-2022
Diabetes Obes Metab, 26 (6), 2102-2110
DOI 10.1111/dom.15515, PubMed 38419410 -
N-terminal pro-B-type natriuretic peptide levels vary by ethnicity and are associated with insulin sensitivity after gestational diabetes mellitus
Cardiovasc Diabetol, 23 (1), 284
DOI 10.1186/s12933-024-02349-1, PubMed 39097697 -
Meal patterns, including intermittent fasting - a scoping review for Nordic Nutrition Recommendations 2023
Food Nutr Res, 68
DOI 10.29219/fnr.v68.10505, PubMed 38370117
Publications 2023
-
Validation and Reproducibility of Total Plaque Thickness in Carotid and Femoral Arteries Using Ultrasound
Ultrasound Med Biol, 50 (2), 207-215
DOI 10.1016/j.ultrasmedbio.2023.09.020, PubMed 37940460 -
Association of Troponin T measurements with long-term outcomes in patients with coronary artery disease participating in a secondary prevention trial
BMC Cardiovasc Disord, 23 (1), 210
DOI 10.1186/s12872-023-03249-0, PubMed 37118703 -
Sex differences in secondary preventive follow-up after coronary heart events
BMC Cardiovasc Disord, 23 (1), 459
DOI 10.1186/s12872-023-03483-6, PubMed 37710178 -
Metabolic profile in women with bulimia nervosa or binge-eating disorder before and after treatment: secondary analysis from the randomized PED-t trial
Eat Weight Disord, 28 (1), 41
DOI 10.1007/s40519-023-01567-y, PubMed 37103592 -
Prevalence, outcomes and costs of a contemporary, multinational population with heart failure
Heart, 109 (7), 548-556
DOI 10.1136/heartjnl-2022-321702, PubMed 36781285 -
Associations between everyday activities and arterial spin labeling-derived cerebral blood flow: A longitudinal study in community-dwelling elderly volunteers
Hum Brain Mapp, 44 (8), 3377-3393
DOI 10.1002/hbm.26287, PubMed 36947581 -
[Correction: High levels of lipoprotein(a) – assessment and treatment]
Tidsskr Nor Laegeforen, 143 (2)
DOI 10.4045/tidsskr.23.0023, PubMed 36718898 -
Protocol for a 20-year follow-up after a randomized controlled trial of a Mediterranean diet in pregnancy: maternal and offspring risk factors for cardiovascular disease
Front Pediatr, 11, 1256815
DOI 10.3389/fped.2023.1256815, PubMed 37920793 -
[Adolescents with severe obesity should receive medication under the National Insurance scheme]
Tidsskr Nor Laegeforen, 143 (3)
DOI 10.4045/tidsskr.23.0069, PubMed 36811423
Publications 2022
-
Do we need new lipid-lowering agents in the era of PCSK9 inhibitors? Recent advances
Kardiol Pol, 80 (7-8), 741-749
DOI 10.33963/KP.a2022.0117, PubMed 35521719 -
Randomized trial of cardiovascular prevention in Norway combining an in-hospital lifestyle course with primary care follow-up: the Hjerteløftet study
Eur J Prev Cardiol, 29 (17), 2252-2263
DOI 10.1093/eurjpc/zwac211, PubMed 36124709 -
The Effect of Smoking Cessation on Body Weight and Other Metabolic Parameters with Focus on People with Type 2 Diabetes Mellitus
Int J Environ Res Public Health, 19 (20)
DOI 10.3390/ijerph192013222, PubMed 36293800 -
Vegetarian and vegan diets and the risk of cardiovascular disease, ischemic heart disease and stroke: a systematic review and meta-analysis of prospective cohort studies
Eur J Nutr, 62 (1), 51-69
DOI 10.1007/s00394-022-02942-8, PubMed 36030329 -
Effect of smoking cessation on cardiac troponin I concentrations
Scand J Clin Lab Invest, 82 (2), 104-107
DOI 10.1080/00365513.2022.2031277, PubMed 35112632 -
Resmetirom (MGL-3196) in Patients With Heterozygous Familial Hypercholesterolemia
J Am Coll Cardiol, 79 (12), 1220-1222
DOI 10.1016/j.jacc.2022.01.023, PubMed 35331419 -
Tobacco and nicotine use
Nat Rev Dis Primers, 8 (1), 19
DOI 10.1038/s41572-022-00346-w, PubMed 35332148 -
Many refugees are at a high risk of cardiovascular disease
Tidsskr Nor Laegeforen, 142 (12)
DOI 10.4045/tidsskr.22.0365, PubMed 36066236 -
Statins seldom cause adverse reactions
Tidsskr Nor Laegeforen, 142 (2)
DOI 10.4045/tidsskr.21.0885, PubMed 35107944 -
Quality of clinical management of cardiometabolic risk factors in patients with severe mental illness in a specialist mental health care setting
Nord J Psychiatry, 76 (8), 602-609
DOI 10.1080/08039488.2022.2039288, PubMed 35200088 -
High levels of lipoprotein(a) - assessment and treatment
Tidsskr Nor Laegeforen, 142 (1)
DOI 10.4045/tidsskr.21.0800, PubMed 36655975 -
Medication-assisted quit rates in participants with smoking-related diseases in EAGLES: Post hoc analyses of a double-blind, randomized, placebo-controlled clinical trial
Tob Induc Dis, 20, 46
DOI 10.18332/tid/146567, PubMed 35611069 -
No add-on effect of tDCS on fatigue and depression in chronic stroke patients: A randomized sham-controlled trial combining tDCS with computerized cognitive training
Brain Behav, 12 (7), e2643
DOI 10.1002/brb3.2643, PubMed 35666655 -
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Rev Esp Cardiol (Engl Ed), 75 (5), 429
DOI 10.1016/j.rec.2022.04.003, PubMed 35525570 -
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Eur J Prev Cardiol, 29 (1), 5-115
DOI 10.1093/eurjpc/zwab154, PubMed 34558602 -
[2021 ESC Guidelines on cardiovascular disease prevention in clinical practice]
G Ital Cardiol (Rome), 23 (6 Suppl 1), e3-e115
DOI 10.1714/3808.37926, PubMed 35708476
Publications 2021
-
Long-term effects (> 24 months) of multiple lifestyle intervention on major cardiovascular risk factors among high-risk subjects: a meta-analysis
BMC Cardiovasc Disord, 21 (1), 181
DOI 10.1186/s12872-021-01989-5, PubMed 33858345 -
Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy: Secondary Analysis From the FOURIER Randomized Clinical Trial
JAMA Cardiol, 6 (2), 139-147
DOI 10.1001/jamacardio.2020.3151, PubMed 32785614 -
Correction to: Cardiovascular risk factors and body composition in adults with achondroplasia
Genet Med, 23 (11), 2234
DOI 10.1038/s41436-021-01201-1, PubMed 34234305 -
Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects - A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial
Circ J, 85 (11), 2063-2070
DOI 10.1253/circj.CJ-20-1051, PubMed 33980763 -
Cue restricted smoking increases quit rates with varenicline
Tob Prev Cessat, 7, 33
DOI 10.18332/tpc/133570, PubMed 34017927 -
LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial
Atherosclerosis, 320, 1-9
DOI 10.1016/j.atherosclerosis.2021.01.003, PubMed 33497862 -
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Eur Heart J, 42 (34), 3227-3337
DOI 10.1093/eurheartj/ehab484, PubMed 34458905
Publications 2020
-
An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial
JAMA Cardiol, 5 (6), 709-713
DOI 10.1001/jamacardio.2020.0728, PubMed 32347887 -
Cardiovascular risk factors and body composition in adults with achondroplasia
Genet Med, 23 (4), 732-739
DOI 10.1038/s41436-020-01024-6, PubMed 33204020 -
Cognition After Lowering LDL-Cholesterol With Evolocumab
J Am Coll Cardiol, 75 (18), 2283-2293
DOI 10.1016/j.jacc.2020.03.039, PubMed 32381158 -
Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: A Prespecified Secondary Analysis From the FOURIER Trial
JAMA Cardiol, 5 (8), 952-957
DOI 10.1001/jamacardio.2020.0882, PubMed 32432684 -
Risk of cardiovascular disease after preventive salpingo-oophorectomy
Int J Gynecol Cancer, 30 (5), 575-582
DOI 10.1136/ijgc-2019-000856, PubMed 32332121 -
Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway project
Atheroscler Suppl, 42, e49-e58
DOI 10.1016/j.atherosclerosissup.2021.01.009, PubMed 33589224 -
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
Eur Heart J, 41 (1), 111-188
DOI 10.1093/eurheartj/ehz455, PubMed 31504418 -
The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism
Circulation, 141 (20), 1600-1607
DOI 10.1161/CIRCULATIONAHA.120.046397, PubMed 32223429 -
Validation of the cardiovascular risk model NORRISK 2 in South Asians and people with diabetes
Scand Cardiovasc J, 55 (1), 56-62
DOI 10.1080/14017431.2020.1821909, PubMed 33073627 -
PLANT-BASED DIET: why you should eat greener, and how to do it in practice
Tidsskr. Nor. Laegeforen., 140 (2), 181 -
Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations
Curr Med Res Opin, 36 (5), 713-730
DOI 10.1080/03007995.2020.1729708, PubMed 32050807 -
Randomized trials of diet and persistent organic pollutants: Reply to Drs. Lee and Lee
Nutr Metab Cardiovasc Dis, 30 (5), 851-852
DOI 10.1016/j.numecd.2020.02.019, PubMed 32276864 -
Effect of Evolocumab on Type and Size of Subsequent Myocardial Infarction: A Prespecified Analysis of the FOURIER Randomized Clinical Trial
JAMA Cardiol, 5 (7), 787-793
DOI 10.1001/jamacardio.2020.0764, PubMed 32347885
Publications 2019
-
It's Time to Bury the "Smoker's Paradox"
Nicotine Tob Res, 21 (9), 1149-1150
DOI 10.1093/ntr/ntz106, PubMed 31231769 -
Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial
J Am Coll Cardiol, 73 (23), 2961-2970
DOI 10.1016/j.jacc.2019.03.513, PubMed 31196453 -
Relation of Lipid-Lowering Therapy to Need for Aortic Valve Replacement in Patients With Asymptomatic Mild to Moderate Aortic Stenosis
Am J Cardiol, 124 (11), 1736-1740
DOI 10.1016/j.amjcard.2019.08.037, PubMed 31586530 -
Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial
Circulation, 141 (8), 616-623
DOI 10.1161/CIRCULATIONAHA.119.043805, PubMed 31707849 -
Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular Disease: A Prespecified Analysis From the FOURIER Trial
JAMA Cardiol, 4 (7), 613-619
DOI 10.1001/jamacardio.2019.0886, PubMed 31116355 -
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk
Circulation, 139 (12), 1483-1492
DOI 10.1161/CIRCULATIONAHA.118.037184, PubMed 30586750 -
Interindividual Variation in Low-Density Lipoprotein Cholesterol Level Reduction With Evolocumab: An Analysis of FOURIER Trial Data
JAMA Cardiol, 4 (1), 59-63
DOI 10.1001/jamacardio.2018.4178, PubMed 30540337
Publications 2018
-
Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies
Am J Clin Nutr, 108 (5), 1069-1091
DOI 10.1093/ajcn/nqy097, PubMed 30475962 -
Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial
JAMA Intern Med, 178 (5), 622-631
DOI 10.1001/jamainternmed.2018.0397, PubMed 29630702 -
Inflammatory and Cholesterol Risk in the FOURIER Trial
Circulation, 138 (2), 131-140
DOI 10.1161/CIRCULATIONAHA.118.034032, PubMed 29530884 -
Exploring the effect of a lifestyle intervention on cancer risk: 43-year follow-up of the randomized Oslo diet and antismoking study
J Intern Med, 284 (3), 282-291
DOI 10.1111/joim.12765, PubMed 29790221 -
Clinical benefits of evolocumab appear less than hoped - Authors' reply
Lancet, 391 (10124), 934-935
DOI 10.1016/S0140-6736(18)30529-4, PubMed 29536853 -
Prevalence of diabetes before and after first diagnosis of coronary artery disease
Tidsskr Nor Laegeforen, 138 (5)
DOI 10.4045/tidsskr.17.0539, PubMed 29513466 -
Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation: Insights From the FOURIER Trial
JAMA Cardiol, 3 (8), 749-753
DOI 10.1001/jamacardio.2018.1533, PubMed 29898218 -
Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial
Clin Cardiol, 41 (10), 1281-1288
DOI 10.1002/clc.23055, PubMed 30125052 -
Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER
Circulation, 138 (8), 756-766
DOI 10.1161/CIRCULATIONAHA.118.034309, PubMed 29626068 -
Coding variants in RPL3L and MYZAP increase risk of atrial fibrillation
Commun Biol, 1, 68
DOI 10.1038/s42003-018-0068-9, PubMed 30271950 -
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
Lancet, 392 (10155), 1311-1320
DOI 10.1016/S0140-6736(18)31652-0, PubMed 30293769
Publications 2017
-
Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies
Int J Epidemiol, 46 (3), 1029-1056
DOI 10.1093/ije/dyw319, PubMed 28338764 -
Physical activity and the risk of preterm birth: a systematic review and meta-analysis of epidemiological studies
BJOG, 124 (12), 1816-1826
DOI 10.1111/1471-0528.14672, PubMed 28374930 -
Body mass index and physical activity and the risk of diverticular disease: a systematic review and meta-analysis of prospective studies
Eur J Nutr, 56 (8), 2423-2438
DOI 10.1007/s00394-017-1443-x, PubMed 28393286 -
Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - A systematic review and dose-response meta-analysis of prospective studies
Nutr Metab Cardiovasc Dis, 27 (6), 504-517
DOI 10.1016/j.numecd.2017.04.004, PubMed 28552551 -
Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies
Eur J Epidemiol, 32 (3), 181-192
DOI 10.1007/s10654-017-0232-4, PubMed 28194602 -
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)
Circulation, 137 (4), 338-350
DOI 10.1161/CIRCULATIONAHA.117.032235, PubMed 29133605 -
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Rev Esp Cardiol (Engl Ed), 70 (2), 115
DOI 10.1016/j.rec.2017.01.002, PubMed 29389351 -
Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease
JAMA Cardiol, 2 (10), 1069-1078
DOI 10.1001/jamacardio.2017.2762, PubMed 28832867 -
Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial
JAMA Cardiol, 2 (12), 1385-1391
DOI 10.1001/jamacardio.2017.3944, PubMed 29117276 -
Cognitive Function in a Randomized Trial of Evolocumab
N Engl J Med, 377 (7), 633-643
DOI 10.1056/NEJMoa1701131, PubMed 28813214 -
Design and rationale of the EBBINGHAUS trial: A phase 3, double-blind, placebo-controlled, multicenter study to assess the effect of evolocumab on cognitive function in patients with clinically evident cardiovascular disease and receiving statin background lipid-lowering therapy-A cognitive study of patients enrolled in the FOURIER trial
Clin Cardiol, 40 (2), 59-65
DOI 10.1002/clc.22678, PubMed 28207168 -
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
Lancet, 390 (10106), 1962-1971
DOI 10.1016/S0140-6736(17)32290-0, PubMed 28859947 -
Effect Modifications of Lipid-Lowering Therapy on Progression of Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] Study)
Am J Cardiol, 121 (6), 739-745
DOI 10.1016/j.amjcard.2017.12.011, PubMed 29361285 -
New guidelines for the prevention of cardiovascular disease
Tidsskr. Nor. Laegeforen., 137 (16), 1164-1168 -
The PED-t trial protocol: The effect of physical exercise -and dietary therapy compared with cognitive behavior therapy in treatment of bulimia nervosa and binge eating disorder
BMC Psychiatry, 17 (1), 180
DOI 10.1186/s12888-017-1312-4, PubMed 28494809 -
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
N Engl J Med, 376 (18), 1713-1722
DOI 10.1056/NEJMoa1615664, PubMed 28304224 -
Evolocumab in Patients with Cardiovascular Disease
N Engl J Med, 377 (8), 787-8
DOI 10.1056/NEJMc1708587, PubMed 28834471 -
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
Lancet Diabetes Endocrinol, 5 (12), 941-950
DOI 10.1016/S2213-8587(17)30313-3, PubMed 28927706 -
A Missense Variant in PLEC Increases Risk of Atrial Fibrillation
J Am Coll Cardiol, 70 (17), 2157-2168
DOI 10.1016/j.jacc.2017.09.005, PubMed 29050564 -
[Statin intolerance]
Tidsskr Nor Laegeforen, 137 (1), 36-38
DOI 10.4045/tidsskr.16.0646, PubMed 28073228 -
Statins for children with familial hypercholesterolemia
Cochrane Database Syst Rev, 7 (7), CD006401
DOI 10.1002/14651858.CD006401.pub4, PubMed 28685504 -
Cardiovascular disease and diabetes by African or Asian background
Tidsskr. Nor. Laegeforen., 137 (22), 1790-1794 -
Cardiovascular disease and diabetes in patients with African or Asian background
Tidsskr Nor Laegeforen, 137 (22)
DOI 10.4045/tidsskr.16.0680, PubMed 29181932
Publications 2016
-
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
Ann Rheum Dis, 76 (1), 17-28
DOI 10.1136/annrheumdis-2016-209775, PubMed 27697765 -
Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective studies
BMC Med, 14 (1), 207
DOI 10.1186/s12916-016-0730-3, PubMed 27916000 -
Body Mass Index, Abdominal Fatness, and Heart Failure Incidence and Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies
Circulation, 133 (7), 639-49
DOI 10.1161/CIRCULATIONAHA.115.016801, PubMed 26746176 -
Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes
Int J Cardiol, 222, 548-556
DOI 10.1016/j.ijcard.2016.07.201, PubMed 27513651 -
Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study
PLoS One, 11 (4), e0153440
DOI 10.1371/journal.pone.0153440, PubMed 27093159 -
The Vertical Drop Jump Is a Poor Screening Test for ACL Injuries: Response
Am J Sports Med, 44 (6), NP24-5
DOI 10.1177/0363546516651042, PubMed 27252548 -
Screening Tests for ACL Injury: Response
Am J Sports Med, 44 (6), NP26-7
DOI 10.1177/0363546516651046, PubMed 27252550 -
Effect of a Low Fat Diet Intervention on Blood Pressure and Hypertension: Rather Switch to a Mediterranean Diet?
Am J Hypertens, 29 (8), 900-3
DOI 10.1093/ajh/hpw054, PubMed 27245068 -
Recommendations to improve smoking cessation outcomes from people with lung conditions who smoke
ERJ Open Res, 2 (2)
DOI 10.1183/23120541.00009-2016, PubMed 27730185 -
Assessing Optimal Blood Pressure in Patients With Asymptomatic Aortic Valve Stenosis: The Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS)
Circulation, 134 (6), 455-68
DOI 10.1161/CIRCULATIONAHA.115.021213, PubMed 27486164 -
The Success Story of LDL Cholesterol Lowering
Circ Res, 118 (4), 721-31
DOI 10.1161/CIRCRESAHA.115.306297, PubMed 26892969 -
Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo-controlled studies of varenicline
J Diabetes Investig, 8 (1), 93-100
DOI 10.1111/jdi.12543, PubMed 27223809
Publications 2015
-
Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis
Circ Cardiovasc Imaging, 8 (11), e003644; discussion e003644
DOI 10.1161/CIRCIMAGING.115.003644, PubMed 26489804 -
Survival in elderly men in relation to midlife and current BMI
Age Ageing, 44 (3), 434-9
DOI 10.1093/ageing/afu202, PubMed 25609234 -
Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention study
Arthritis Res Ther, 17, 279
DOI 10.1186/s13075-015-0795-y, PubMed 26445924 -
Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit
Eur Respir J, 46 (1), 61-79
DOI 10.1183/09031936.00092614, PubMed 25882805 -
Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism
Transplantation, 99 (2), 351-9
DOI 10.1097/TP.0000000000000583, PubMed 25594550 -
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials
Eur Heart J, 36 (24), 1536-46
DOI 10.1093/eurheartj/ehv072, PubMed 25802390 -
Association of Chest Pain and Risk of Cardiovascular Disease with Coronary Atherosclerosis in Patients with Inflammatory Joint Diseases
Front Med (Lausanne), 2, 80
DOI 10.3389/fmed.2015.00080, PubMed 26618159 -
Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study
Arthritis Rheumatol, 67 (7), 1718-28
DOI 10.1002/art.39114, PubMed 25778850 -
Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
Am Heart J, 173, 94-101
DOI 10.1016/j.ahj.2015.11.015, PubMed 26920601 -
High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease
Heart, 101 (5), 356-62
DOI 10.1136/heartjnl-2014-306906, PubMed 25595417 -
Dynamic path analysis - a useful tool to investigate mediation processes in clinical survival trials
Stat Med, 34 (29), 3866-87
DOI 10.1002/sim.6598, PubMed 26278111
Publications 2014
-
Physical activity and the risk of preeclampsia: a systematic review and meta-analysis
Epidemiology, 25 (3), 331-43
DOI 10.1097/EDE.0000000000000036, PubMed 24713878 -
Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and meta-analysis
JAMA, 311 (15), 1536-46
DOI 10.1001/jama.2014.2269, PubMed 24737366 -
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials
J Am Coll Cardiol, 64 (5), 485-94
DOI 10.1016/j.jacc.2014.02.615, PubMed 25082583 -
Uric acid and clinical correlates of endothelial function in kidney transplant recipients
Clin Transplant, 28 (10), 1167-76
DOI 10.1111/ctr.12435, PubMed 25124959 -
Incidence of cancer and mortality in patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial
Am J Cardiol, 114 (10), 1518-22
DOI 10.1016/j.amjcard.2014.08.016, PubMed 25267716 -
[Physical activity, smoking and mortality among men who participated in the Oslo studies of 1972 and 2000]
Tidsskr Nor Laegeforen, 134 (18), 1743-8
DOI 10.4045/tidsskr.14.0073, PubMed 25273247 -
Increased predictive ability of BMI but not other risk factors with time in men: 39-year follow-up of total mortality in the Oslo Study
Obes Facts, 7 (5), 311-21
DOI 10.1159/000368567, PubMed 25300406 -
Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF
Heart, 100 (24), 1946-53
DOI 10.1136/heartjnl-2014-305763, PubMed 25217488 -
Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial
Eur Heart J, 35 (21), 1411-20
DOI 10.1093/eurheartj/ehu051, PubMed 24616337 -
Adjusting parameters of aortic valve stenosis severity by body size
Heart, 100 (13), 1024-30
DOI 10.1136/heartjnl-2013-305225, PubMed 24780909 -
Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipients
Transplantation, 98 (11), 1219-25
DOI 10.1097/TP.0000000000000205, PubMed 24999963 -
Impact of obesity and nonobesity on grading the severity of aortic valve stenosis
Am J Cardiol, 113 (9), 1532-5
DOI 10.1016/j.amjcard.2014.01.429, PubMed 24630788 -
Systemic inflammation in patients with inflammatory joint diseases does not influence statin dose needed to obtain LDL cholesterol goal in cardiovascular prevention
Ann Rheum Dis, 74 (8), 1544-50
DOI 10.1136/annrheumdis-2013-204636, PubMed 24699940 -
The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice
Atheroscler Suppl, 15 (1), 1-15
DOI 10.1016/j.atherosclerosissup.2014.04.001, PubMed 24840509 -
Maternal life course socio-economic position and offspring body composition at birth in a multi-ethnic population
Paediatr Perinat Epidemiol, 28 (5), 445-54
DOI 10.1111/ppe.12137, PubMed 25060595 -
Darapladib for preventing ischemic events in stable coronary heart disease
N Engl J Med, 370 (18), 1702-11
DOI 10.1056/NEJMoa1315878, PubMed 24678955 -
The effect of kiwifruit consumption on blood pressure in subjects with moderately elevated blood pressure: a randomized, controlled study
Blood Press, 24 (1), 48-54
DOI 10.3109/08037051.2014.976979, PubMed 25483553 -
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
Lancet, 385 (9965), 351-61
DOI 10.1016/S0140-6736(14)61183-1, PubMed 25262344 -
Symptoms of nicotine toxicity in subjects achieving high cotinine levels during nicotine replacement therapy
Nicotine Tob Res, 16 (9), 1266-71
DOI 10.1093/ntr/ntu076, PubMed 24852574 -
Statins for children with familial hypercholesterolemia
Cochrane Database Syst Rev (7), CD006401
DOI 10.1002/14651858.CD006401.pub3, PubMed 25054950
Publications 2013
-
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis
Circulation, 128 (14), 1504-12
DOI 10.1161/CIRCULATIONAHA.113.002670, PubMed 23965489 -
High-dose statin therapy in patients with stable coronary artery disease: treating the right patients based on individualized prediction of treatment effect
Circulation, 127 (25), 2485-93
DOI 10.1161/CIRCULATIONAHA.112.000712, PubMed 23674398 -
Reduced binding to nicotinic receptors after nicotine vaccination: is the effect big enough to be clinically meaningful?
Am J Psychiatry, 170 (4), 359-61
DOI 10.1176/appi.ajp.2012.12121604, PubMed 23545789 -
Natural history of mild and of moderate aortic stenosis-new insights from a large prospective European study
Curr Probl Cardiol, 38 (9), 365-409
DOI 10.1016/j.cpcardiol.2013.06.003, PubMed 23972937 -
[Tor Ole Klemsdal replies]
Tidsskr Nor Laegeforen, 133 (6), 614
DOI 10.4045/tidsskr.13.0277, PubMed 23552149 -
Safety and effect of very low levels of low-density lipoprotein cholesterol on cardiovascular events
Am J Cardiol, 111 (8), 1221-9
DOI 10.1016/j.amjcard.2012.12.052, PubMed 23375731 -
Self-reported exercise and bone mineral density in prostate cancer patients receiving androgen deprivation therapy
J Am Assoc Nurse Pract, 26 (1), 40-48
DOI 10.1002/2327-6924.12066, PubMed 24170604 -
Long-term risks for kidney donors
Kidney Int, 86 (1), 162-7
DOI 10.1038/ki.2013.460, PubMed 24284516 -
Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients
Clin Transplant, 28 (1), 111-9
DOI 10.1111/ctr.12285, PubMed 24372612 -
Determinants of cardiovascular risk in haemodialysis patients: post hoc analyses of the AURORA study
Am J Nephrol, 37 (2), 144-51
DOI 10.1159/000346710, PubMed 23392089 -
Triglycerides-diabetes association in healthy middle-aged men: modified by physical fitness? A long term follow-up of 1962 Norwegian men in the Oslo Ischemia Study
Diabetes Res Clin Pract, 101 (2), 201-9
DOI 10.1016/j.diabres.2013.06.001, PubMed 23827210 -
Ethnic differences in neonatal body composition in a multi-ethnic population and the impact of parental factors: a population-based cohort study
PLoS One, 8 (8), e73058
DOI 10.1371/journal.pone.0073058, PubMed 24009731 -
The external validation of the cardiovascular risk equation for renal transplant recipients: applications to BENEFIT and BENEFIT-EXT trials
Transplantation, 95 (1), 142-7
DOI 10.1097/TP.0b013e31827722c9, PubMed 23192156 -
Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels
Int J Cardiol, 168 (4), 3846-52
DOI 10.1016/j.ijcard.2013.06.024, PubMed 24001698 -
Weight gain does not attenuate cardiovascular benefits of smoking cessation
Evid Based Med, 19 (1), 25
DOI 10.1136/eb-2013-101350, PubMed 23723383 -
Niccine®, a nicotine vaccine, for relapse prevention: a phase II, randomized, placebo-controlled, multicenter clinical trial
Nicotine Tob Res, 15 (9), 1492-501
DOI 10.1093/ntr/ntt003, PubMed 23471101 -
Reply: To PMID 23219296
J Am Coll Cardiol, 61 (18), 1934
DOI 10.1016/j.jacc.2013.02.015, PubMed 23500266
Publications 2012
-
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis
JAMA, 307 (12), 1302-9
DOI 10.1001/jama.2012.366, PubMed 22453571 -
The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial
Diabetes Care, 35 (5), 1095-7
DOI 10.2337/dc11-1895, PubMed 22446172 -
Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095-1097
Diabetes Care, 35 (11), E80
DOI 10.2337/dc12-1124 -
Effect of a low-fat versus a low-gycemic-load diet on inflammatory biomarker and adipokine concentrations
Metab Syndr Relat Disord, 10 (6), 437-42
DOI 10.1089/met.2012.0012, PubMed 22889406 -
Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipients
Clin J Am Soc Nephrol, 8 (2), 241-7
DOI 10.2215/CJN.03760412, PubMed 23160259 -
Kiwifruit decreases blood pressure and whole-blood platelet aggregation in male smokers
J Hum Hypertens, 27 (2), 126-30
DOI 10.1038/jhh.2011.116, PubMed 22258209 -
Correction: "Reduction in BMI z-score and improvement in cardiometabolic risk factors in obese children and adolescents. The Oslo adiposity intervention study - a hospital/public health nurse combined treatment."
BMC Pediatr, 12, 77
DOI 10.1186/1471-2431-12-77, PubMed 22709339 -
Lipid-modifying therapies and risk of pancreatitis: a meta-analysis
JAMA, 308 (8), 804-11
DOI 10.1001/jama.2012.8439, PubMed 22910758 -
Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic
Ann Rheum Dis, 72 (12), 1968-74
DOI 10.1136/annrheumdis-2012-202789, PubMed 23264359 -
Effects of dalcetrapib in patients with a recent acute coronary syndrome
N Engl J Med, 367 (22), 2089-99
DOI 10.1056/NEJMoa1206797, PubMed 23126252 -
Prediction of cardiovascular events in patients with ankylosing spondylitis and psoriatic arthritis: role of lipoproteins in a high-risk population
J Rheumatol, 39 (7), 1433-40
DOI 10.3899/jrheum.111307, PubMed 22660802 -
Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease
Arthritis Rheum, 64 (9), 2836-46
DOI 10.1002/art.34524, PubMed 22576673 -
Assessment of volar angulation and shortening in 5th metacarpal neck fractures: an inter- and intra-observer validity and reliability study
J Hand Surg Eur Vol, 38 (6), 658-66
DOI 10.1177/1753193412461582, PubMed 23060463 -
A cardiovascular risk calculator for renal transplant recipients
Transplantation, 94 (1), 57-62
DOI 10.1097/TP.0b013e3182516cdc, PubMed 22683851 -
Efficacy of a dose range of surinabant, a cannabinoid receptor blocker, for smoking cessation: a randomized controlled clinical trial
J Psychopharmacol, 26 (7), 1003-9
DOI 10.1177/0269881111431623, PubMed 22219220 -
Associations between temperament at age 1.5 years and obesogenic diet at ages 3 and 7 years
J Dev Behav Pediatr, 33 (9), 721-7
DOI 10.1097/DBP.0b013e31826bac0d, PubMed 23117597 -
Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes
J Am Coll Cardiol, 61 (2), 148-52
DOI 10.1016/j.jacc.2012.09.042, PubMed 23219296
Publications 2011
-
The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies
Circ Cardiovasc Genet, 5 (1), 51-7
DOI 10.1161/CIRCGENETICS.111.960252, PubMed 22135385 -
Inflammation-associated graft loss in renal transplant recipients
Nephrol Dial Transplant, 26 (11), 3756-61
DOI 10.1093/ndt/gfr163, PubMed 21511816 -
[Good effect of varenicline in snuff use cessation. Double-blind placebo controlled comparative study]
Lakartidningen, 108 (44), 2215-7
PubMed 22165180 -
Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
Int J Cardiol, 166 (1), 72-6
DOI 10.1016/j.ijcard.2011.09.064, PubMed 21996417 -
Rosuvastatin in diabetic hemodialysis patients
J Am Soc Nephrol, 22 (7), 1335-41
DOI 10.1681/ASN.2010090987, PubMed 21566054 -
[Risk factors and mortality--a follow-up of the Oslo Health Study from 1972-73]
Tidsskr Nor Laegeforen, 131 (5), 456-60
DOI 10.4045/tidsskr.10.0342, PubMed 21383797 -
High blood hemoglobin concentration as risk factor of major atherosclerotic cardiovascular events in 114,159 healthy men and women in the apolipoprotein mortality risk study (AMORIS)
Ann Med, 44 (5), 476-86
DOI 10.3109/07853890.2011.573804, PubMed 21585246 -
Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population
Ann Med, 44 (6), 607-15
DOI 10.3109/07853890.2011.582136, PubMed 21612332 -
Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction
Circulation, 123 (8), 887-95
DOI 10.1161/CIRCULATIONAHA.110.983510, PubMed 21321152 -
Response to Letters Regarding Article, "Outcome of Patients With Low-Gradient "Severe" Aortic Stenosis and Preserved Ejection Fraction"
Circulation, 124 (13), E362-E363
DOI 10.1161/CIRCULATIONAHA.111.045203 -
Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study
Eur J Endocrinol, 166 (2), 317-24
DOI 10.1530/EJE-11-0866, PubMed 22108914 -
Compliance, tolerability and safety of two antioxidant-rich diets: a randomised controlled trial in male smokers
Br J Nutr, 106 (4), 557-71
DOI 10.1017/S0007114511000353, PubMed 21806852 -
Reduction in BMI z-score and improvement in cardiometabolic risk factors in obese children and adolescents. The Oslo Adiposity Intervention Study - a hospital/public health nurse combined treatment
BMC Pediatr, 11, 47
DOI 10.1186/1471-2431-11-47, PubMed 21619652 -
Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis
Clin J Am Soc Nephrol, 6 (6), 1316-25
DOI 10.2215/CJN.09121010, PubMed 21493741 -
Norway's new principles for primary prevention of cardiovascular disease: age differentiated risk thresholds
BMJ-British Medical Journal, 343, d3626
DOI 10.1136/bmj.d3626 -
LDL cholesterol goals and cardiovascular risk during statin treatment: the IDEAL study
Eur J Cardiovasc Prev Rehabil, 18 (2), 262-9
DOI 10.1177/1741826710389391, PubMed 21450674 -
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
JAMA, 305 (24), 2556-64
DOI 10.1001/jama.2011.860, PubMed 21693744 -
HDL-cholesterol and prediction of coronary heart disease: modified by physical fitness? A 28-year follow-up of apparently healthy men
Atherosclerosis, 220 (1), 250-6
DOI 10.1016/j.atherosclerosis.2011.10.009, PubMed 22062589 -
Orlistat after initial dietary/behavioural treatment: changes in body weight and dietary maintenance in subjects with sleep related breathing disorders
Nutr J, 10, 21
DOI 10.1186/1475-2891-10-21, PubMed 21385420
Publications 2010
-
Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients
Kidney Int, 77 (1), 44-50
DOI 10.1038/ki.2009.382, PubMed 19847152 -
A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study
Int J Obes (Lond), 34 (5), 919-35
DOI 10.1038/ijo.2010.21, PubMed 20157323 -
Blood cell gene expression associated with cellular stress defense is modulated by antioxidant-rich food in a randomised controlled clinical trial of male smokers
BMC Med, 8, 54
DOI 10.1186/1741-7015-8-54, PubMed 20846424 -
A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk
Eur J Cardiovasc Prev Rehabil, 17 (5), 588-92
DOI 10.1097/HJR.0b013e328339cc70, PubMed 20389249 -
Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial
BMJ, 341, c6549
DOI 10.1136/bmj.c6549, PubMed 21134997 -
Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study)
Am J Cardiol, 106 (11), 1634-9
DOI 10.1016/j.amjcard.2010.07.042, PubMed 21094366 -
Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial
Am J Cardiol, 105 (12), 1802-8
DOI 10.1016/j.amjcard.2010.01.363, PubMed 20538134 -
Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Atherosclerosis, 213 (1), 299-305
DOI 10.1016/j.atherosclerosis.2010.08.049, PubMed 20843515 -
Bilberry juice modulates plasma concentration of NF-kappaB related inflammatory markers in subjects at increased risk of CVD
Eur J Nutr, 49 (6), 345-55
DOI 10.1007/s00394-010-0092-0, PubMed 20119859 -
Coronary heart disease risk profile in women who underwent salpingo-oophorectomy to prevent hereditary breast ovarian cancer
Int J Gynecol Cancer, 20 (2), 233-9
DOI 10.1111/igc.0b013e3181ca5ff4, PubMed 20169665 -
One- and five-year follow-ups on blood pressure and renal function in kidney donors
Transpl Int, 24 (1), 73-7
DOI 10.1111/j.1432-2277.2010.01148.x, PubMed 20723180 -
Comparison of atorvastatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late (five years) after acute myocardial infarction (from the Incremental Decrease in End Points through Aggressive Lipid Lowering [IDEAL] trial)
Am J Cardiol, 106 (3), 354-9
DOI 10.1016/j.amjcard.2010.03.033, PubMed 20643245 -
Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial
Circulation, 121 (2), 221-9
DOI 10.1161/CIRCULATIONAHA.109.869008, PubMed 20048210 -
Response to Letter Regarding Article, "Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease: A Randomized Trial"
Circulation, 122 (9), E446
DOI 10.1161/CIRCULATIONAHA.110.960856 -
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Lancet, 375 (9716), 735-42
DOI 10.1016/S0140-6736(09)61965-6, PubMed 20167359 -
Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial
Rheumatology (Oxford), 50 (2), 324-9
DOI 10.1093/rheumatology/keq295, PubMed 20884656 -
Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study
Ann Rheum Dis, 69 (11), 1996-2001
DOI 10.1136/ard.2009.126128, PubMed 20551156 -
Suggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe)
BMC Med Genet, 11, 144
DOI 10.1186/1471-2350-11-144, PubMed 20939869 -
Effect of playing tactics on goal scoring in Norwegian professional soccer
J Sports Sci, 28 (3), 237-44
DOI 10.1080/02640410903502774, PubMed 20391095 -
Effect of playing tactics on achieving score-box possessions in a random series of team possessions from Norwegian professional soccer matches
J Sports Sci, 28 (3), 245-55
DOI 10.1080/02640410903502766, PubMed 20391096 -
Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis
Drug Saf, 33 (4), 289-301
DOI 10.2165/11319180-000000000-00000, PubMed 20297861 -
Dianicline, a novel α4β2 nicotinic acetylcholine receptor partial agonist, for smoking cessation: a randomized placebo-controlled clinical trial
Nicotine Tob Res, 13 (1), 1-6
DOI 10.1093/ntr/ntq191, PubMed 21041839 -
On-treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets study
Eur J Clin Invest, 41 (2), 134-42
DOI 10.1111/j.1365-2362.2010.02387.x, PubMed 20868450 -
Infant temperament is associated with potentially obesogenic diet at 18 months
Int J Pediatr Obes, 6 (2-2), e408-14
DOI 10.3109/17477166.2010.518240, PubMed 20854098 -
Statins for children with familial hypercholesterolemia
Cochrane Database Syst Rev (7), CD006401
DOI 10.1002/14651858.CD006401.pub2, PubMed 20614444